GOTHENBURG, Sweden, July 3, 2024 /PRNewswire/ — Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2024. The presentation will be held in English.
Time: Wednesday 17 July, 2024 at 10.00 a.m. CET.
To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group
Vitrolife Group participants:
Bronwyn Brophy O´Connor, CEO
Patrik Tolf, CFO
The press release for the interim report will be released at 8.00 CET on the same day.
Before the conference call, presentation material will be available at the company web page.
A recorded version of the telephone conference will be available for seven days on number +44 (0) 20 3451 9993 (International), access code 7692641#.
Gothenburg, 3 July 2024
VITROLIFE AB (publ)
Contact:
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/vitrolife-ab–publ-/r/conference-call-interim-report,c4010494
The following files are available for download:
|
Conference call interim report |
SOURCE Vitrolife AB (publ)
VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…
AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…
– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…
tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…
Investment to accelerate the growth of a post-acute care platform focused on reducing hospital readmissions…
IRVING, Texas, Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation…